Research
Metabolic adaptation
GIPR agonism enhances the insulin-sensitizing effect of the thiazolidinedione rosiglitazone.
Incorporating GIPR agonists could enhance the effectiveness of insulin-sensitizing medications.
StrongSupportsmedium confidence
It enhanced the insulin-sensitivity effect of this TZD.
Why this rating
Based on the experimental design involving genetic and pharmacological approaches.
Source
GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice
Ellen C Furber et al. · Diabetes · 2023
otherCited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →